Mastermind Discussion: Rethinking the Bench to Bedside Approach in Gene Therapy Development

Time: 3:30 pm
day: Conference Day One

Details:

• Challenging the traditional linear model of drug development for gene therapies
• Highlighting the limitations of relying solely on preclinical data for human trials
• Discussing the relevance of preclinical data when adverse events arise in human trials
• Emphasizing the importance of back and forth between basic and clinical science to refine the therapeutic approach for AAV gene therapies